Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peripheral targets in obesity treatment: a comprehensive update
Antonios Chatzigeorgiou, Eleni Kandaraki, Athanasios G. Papavassiliou, et al.
Obesity Reviews (2014) Vol. 15, Iss. 6, pp. 487-503
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

DNA methylation markers in obesity, metabolic syndrome, and weight loss
Mirian Samblas, Fermı́n I. Milagro, J. Alfredo Martínéz
Epigenetics (2019) Vol. 14, Iss. 5, pp. 421-444
Open Access | Times Cited: 193
Marine Algae as a Potential Source for Anti-Obesity Agents
Wan-Loy Chu, Phang Siew-Moi
Marine Drugs (2016) Vol. 14, Iss. 12, pp. 222-222
Open Access | Times Cited: 161
Flavonoids as antiobesity agents: A review
Ana T. Rufino, Vera Marisa Costa, Félix Carvalho, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 1, pp. 556-585
Closed Access | Times Cited: 133
The Whitening of Brown Fat and Its Implications for Weight Management in Obesity
Ippei Shimizu, Kenneth Walsh
Current Obesity Reports (2015) Vol. 4, Iss. 2, pp. 224-229
Closed Access | Times Cited: 121
Marine-derived bioactive compounds with anti-obesity effect: A review
Xiaoqian Hu, Ningping Tao, Xichang Wang, et al.
Journal of Functional Foods (2016) Vol. 21, pp. 372-387
Closed Access | Times Cited: 92
Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease
Angeliki Katsarou, Ioannis I. Moustakas, Iryna Pyrina, et al.
World Journal of Gastroenterology (2020) Vol. 26, Iss. 17, pp. 1993-2011
Open Access | Times Cited: 83
Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease
Aigli‐Ioanna Legaki, Ioannis I. Moustakas, Michalina Sikorska, et al.
Current Obesity Reports (2022) Vol. 11, Iss. 3, pp. 126-143
Open Access | Times Cited: 57
Matairesinol Nanoparticles Restore Chemosensitivity and Suppress Colorectal Cancer Progression in Preclinical Models: Role of Lipid Metabolism Reprogramming
Shenshen Wu, Jiajia Wang, Zan Fu, et al.
Nano Letters (2023) Vol. 23, Iss. 5, pp. 1970-1980
Closed Access | Times Cited: 20
Seaweed Supplements Normalise Metabolic, Cardiovascular and Liver Responses in High-Carbohydrate, High-Fat Fed Rats
Senthil Arun Kumar, Marie Magnusson, Leigh C. Ward, et al.
Marine Drugs (2015) Vol. 13, Iss. 2, pp. 788-805
Open Access | Times Cited: 51
Obesity: The Metabolic Disease, Advances on Drug Discovery and Natural Product Research
Mafalda Castro, Marco Preto, Vı́tor Vasconcelos, et al.
Current Topics in Medicinal Chemistry (2016) Vol. 16, Iss. 23, pp. 2577-2604
Open Access | Times Cited: 40
Reduced gene expression of sirtuins and active AMPK levels in children and adolescents with obesity and insulin resistance
Zahra Arab Sadeghabadi, Mitra Nourbakhsh, Parvin Pasalar, et al.
Obesity Research & Clinical Practice (2017) Vol. 12, Iss. 2, pp. 167-173
Closed Access | Times Cited: 39
GDNF secreted from adipose-derived stem cells stimulates VEGF-independent angiogenesis
Zhaohui Zhong, Huiying Gu, Jirun Peng, et al.
Oncotarget (2016) Vol. 7, Iss. 24, pp. 36829-36841
Open Access | Times Cited: 38
Precision Obesity Treatments Including Pharmacogenetic and Nutrigenetic Approaches
Maite Solas, Fermı́n I. Milagro, Diego Martínez‐Urbistondo, et al.
Trends in Pharmacological Sciences (2016) Vol. 37, Iss. 7, pp. 575-593
Closed Access | Times Cited: 37
Current trends and future prospects of lipstatin: a lipase inhibitor and pro-drug for obesity
Punit Kumar, Kashyap Kumar Dubey
RSC Advances (2015) Vol. 5, Iss. 106, pp. 86954-86966
Closed Access | Times Cited: 36
Hepatic Senescence Accompanies the Development of NAFLD in Non-Aged Mice Independently of Obesity
Ioannis I. Moustakas, Angeliki Katsarou, Aigli‐Ioanna Legaki, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3446-3446
Open Access | Times Cited: 24
Advanced glycation end products interfere in luteinizing hormone and follicle stimulating hormone signaling in human granulosa KGN cells
Eleni Kandaraki, Antonios Chatzigeorgiou, Efstathia Papageorgiou, et al.
Experimental Biology and Medicine (2017) Vol. 243, Iss. 1, pp. 29-33
Open Access | Times Cited: 29
Fate of Adipose Progenitor Cells in Obesity-Related Chronic Inflammation
Iryna Pyrina, Kyoung‐Jin Chung, Zoi Michailidou, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 24
Current and experimental pharmacotherapy for the management of non-alcoholic fatty liver disease
Angeliki Katsarou, Georgios Tsioulos, Eva Kassi, et al.
HORMONES (2024) Vol. 23, Iss. 4, pp. 621-636
Closed Access | Times Cited: 3
Natural Course of Metabolically Healthy Overweight/Obese Subjects and the Impact of Weight Change
Ruizhi Zheng, Chengguo Liu, Chunmei Wang, et al.
Nutrients (2016) Vol. 8, Iss. 7, pp. 430-430
Open Access | Times Cited: 23
Antiobesity, Antidiabetic, Antioxidative, and Antihyperlipidemic Activities of Bioactive Seaweed Substances
Zhanyi Sun, Zengying Dai, Wenchao Zhang, et al.
Elsevier eBooks (2018), pp. 239-253
Closed Access | Times Cited: 22
Cardiometabolic Syndrome: An Update on Available Mouse Models
Dimitra Aravani, Eva Kassi, Antonios Chatzigeorgiou, et al.
Thrombosis and Haemostasis (2020) Vol. 121, Iss. 06, pp. 703-715
Open Access | Times Cited: 19
Development of QSAR model using machine learning and molecular docking study of polyphenol derivatives against obesity as pancreatic lipase inhibitor
Shristi Modanwal, Akhilesh Kumar Maurya, Saurav Kumar Mishra, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 14, pp. 6569-6580
Closed Access | Times Cited: 11
Analysis of the Role of Stellate Cell VCAM-1 in NASH Models in Mice
Kyoung‐Jin Chung, Aigli‐Ioanna Legaki, Grigorios Papadopoulos, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4813-4813
Open Access | Times Cited: 5
Plumbagin exerts antiobesity effects through inhibition of pancreatic lipase and adipocyte differentiation
Sarayu Pai, Elvis A. F. Martis, Samidha Joshi, et al.
Phytotherapy Research (2018) Vol. 32, Iss. 8, pp. 1631-1635
Open Access | Times Cited: 15
Multi-Target Drugs Against Metabolic Disorders
Luciana Scotti, Alex Monteiro, Jéssika de Oliveira Viana, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2018) Vol. 19, Iss. 4, pp. 402-418
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top